人多能干细胞分化为肝细胞的高级技术与待实现的临床应用
肝移植是多种肝病的唯一治愈手段,但供体器官严重不足;原代肝细胞移植虽有一定前景,却受限于来源和无法体外扩增。人多能干细胞(hPSCs)可无限扩增并分化为肝细胞,但现有分化方案获得的细胞更接近胎儿而非成人肝细胞。本文综述了近年来肝细胞分化方案的技术改进及已开发或近期有望实现的临床策略。
要点
- 肝移植供体短缺推动hPSCs来源肝细胞作为替代方案的研究。
- 现有hPSC分化肝细胞更接近胎儿表型,而非成人肝细胞。
- 三维培养可长期维持肝细胞,但原代肝细胞仍难以体外扩增。
核心结论
- hPSCs可分化为肝细胞,但现有分化产物更接近胎儿肝细胞,需技术改进以推进临床。
研究设计与样本
- 综述,检索并汇总hPSC向肝细胞分化的技术改进及临床转化研究。
主要发现
- 原代肝细胞来源有限且二维培养无法扩增,三维培养可实现长期培养但原代肝细胞仍难体外扩增。
- hPSCs可无限扩增并分化为包括肝细胞在内的任何细胞类型。
- 多个团队的分化方案所得细胞普遍呈现胎儿而非成人肝细胞特征。
临床怎么用
- 关注hPSC来源肝细胞的分化成熟度改进,作为肝移植和肝细胞移植的潜在替代来源。
局限性
- 现有分化方案获得的肝细胞更接近胎儿表型,尚未达到成人肝细胞特征。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
Liver transplantation is currently the only curative treatment for several liver diseases such as acute liver failure, end-stage liver disorders, primary liver cancers, and certain genetic conditions. Unfortunately, despite improvements to transplantation techniques, including live donor transplantation, the number of organs available remains insufficient to meet patient needs. Hepatocyte transplantation has enabled some encouraging results as an alternative to organ transplantation, but primary hepatocytes are little available and cannot be amplified using traditional two-dimensional culture systems. Indeed, although recent studies have tended to show that three-dimensional culture enables long-term hepatocyte culture, it is still agreed that, like most adult primary cell types, hepatocytes remain refractory to in vitro expansion. Because of their exceptional properties, human pluripotent stem cells (hPSCs) can be amplified indefinitely and differentiated into any cell type, including liver cells. While many teams have worked on hepatocyte differentiation, there has been a consensus that cells obtained after hPSC differentiation have more fetal than adult hepatocyte characteristics. New technologies have been used to improve the differentiation process in recent years. This review discusses the technical improvements made to hepatocyte differentiation protocols and the clinical approaches developed to date and anticipated in the near future.
引用
- Luce E, Messina A, Duclos-Vallée JC, et al. Advanced Techniques and Awaited Clinical Applications for Human Pluripotent Stem Cell Differentiation into Hepatocytes. Hepatology. 2021. PMID: 33420753. doi:10.1002/hep.31705
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。